MedX Health Management

Management Kriterienprüfungen 3/4

MedX Health CEO ist Stephen Lockyer , ernannt in May 2023, hat eine Amtszeit von 1.5 Jahren. besitzt direkt 0.04% der Aktien des Unternehmens, im Wert von CA$5.90K . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3.4 Jahre bzw. 6.5 Jahre.

Wichtige Informationen

Stephen Lockyer

Geschäftsführender

CA$112.1k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	1.5yrs
Eigentum des Geschäftsführers	0.04%
Durchschnittliche Amtszeit des Managements	3.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	6.5yrs

Jüngste Management Updates

Recent updates

Geschäftsführer

Stephen Lockyer

1.5yrs

Amtszeit

CA$112,123

Vergütung

Mr. Stephen Lockyer serves as Director of MedX Health Corp since April 12, 2023 and serves as its Chief Executive Officer since May 09, 2023. He co founded Cornwallis Financial Corporation and serves as it...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Stephen Lockyer	CEO & Director	1.5yrs	CA$112.12k	0.040% CA$ 5.9k
Christopher Freeman	Corporate Secretary & Acting CFO	2.6yrs	CA$6.73k	keine Daten
Michael Druhan	President of Dermatological Services & Products	4.2yrs	CA$284.85k	keine Daten
Scott Naughton	Managing Director of US Operations	7.9yrs	keine Daten	keine Daten

3.4yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrenes Management: MDXDas Führungsteam des Unternehmens gilt als erfahren (3.4 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Stephen Lockyer	CEO & Director	1.6yrs	CA$112.12k	0.040% CA$ 5.9k
David Henniger	Independent Vice Chairman	23yrs	keine Daten	0.37% CA$ 55.0k
Kenneth McKay	Independent Chairman	23yrs	keine Daten	0.32% CA$ 47.7k
Daniel Siegel	Member of Medical Advisory Board	6.5yrs	keine Daten	keine Daten
Dennis Reich	Member of Medical Advisory Board	7.8yrs	keine Daten	keine Daten
Trevor Champagne	Chairman of Medical Advisory Board	6.3yrs	keine Daten	keine Daten
Joe Walls	Member of Medical Advisory Board	no data	keine Daten	keine Daten
Per Hall	Member of Medical Advisory Board	no data	keine Daten	keine Daten
Edmund Ho	Independent Director	1.6yrs	keine Daten	4.53% CA$ 673.5k

6.5yrs

Durchschnittliche Betriebszugehörigkeit

73yo

Durchschnittliches Alter

Erfahrener Vorstand: MDXDie Vorstandsmitglieder gelten als erfahren (6.5 Jahre durchschnittliche Amtszeit).

MedX Health Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

MedX Health Corp, Annual General Meeting, Dec 10, 2024

CEO & Director exercised options to buy CA$1.3m worth of stock.

MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

New major risk - Market cap size

MedX Health Corp, Annual General Meeting, Dec 10, 2024

Second quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 2Q 2023)

New major risk - Market cap size

MedX Health Corp announced that it has received CAD 1.05 million in funding

First quarter 2024 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 1Q 2023)

Full year 2023 earnings released: CA$0.023 loss per share (vs CA$0.028 loss in FY 2022)

MedX Health Corp announced that it expects to receive CAD 2 million in funding

New major risk - Share price stability

Third quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.006 loss in 3Q 2022)

CEO & Director exercised options to buy CA$1.3m worth of stock.

MedX Health Corp announced that it has received CAD 1.02 million in funding

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 2Q 2022)

New major risk - Share price stability

First quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 1Q 2022)

MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director

Full year 2022 earnings released: CA$0.028 loss per share (vs CA$0.03 loss in FY 2021)

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited

Third quarter 2022 earnings released: CA$0.006 loss per share (vs CA$0.009 loss in 3Q 2021)

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited

Second quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 2Q 2021)

MedX Health Corp announced that it expects to receive CAD 4 million in funding

Full year 2021 earnings released: CA$0.03 loss per share (vs CA$0.019 loss in FY 2020)

MedX Health Corp announced that it expects to receive CAD 4 million in funding

Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Chairman of the Board Robert von der Porten has left the company

Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.004 loss in 2Q 2020)

COO & MD of Light Therapy Products recently sold CA$53k worth of stock

First quarter 2021 earnings released: CA$0.006 loss per share (vs CA$0.005 loss in 1Q 2020)

MedX Health Corp announced that it expects to receive CAD 2.5 million in funding

Full year 2020 earnings released: CA$0.019 loss per share (vs CA$0.023 loss in FY 2019)

MedX Health Corp. Announces Retirement of Board Members

EMPOWER CLINICS INC. and MedX Health Corporation Announce Memorandum of Understanding to Pilot MedX's Leading-Edge DermSecure Screening Platform At Two Select Empower Clinics Locations in Ontario

MedX Health Corp. Announces the Appointment of Paul Karam as Sales and Marketing Director for Europe, Middle East, Africa (EMEA)

New 90-day high: CA$0.24

MedX Health Corp announced that it expects to receive CAD 4 million in funding

MedX Health Corporation Appoints Trevor Champagne as Chair Medical Advisory Board

Medx Health Corp. Announces the Rollout of DermSecure in the Netherlands

Third quarter 2020 earnings released: CA$0.006 loss per share

MedX Health Corp Announces Board Changes

Medx Health Corp. Appoints Anthony Milonas and Wayne Cockburn as Directors

First half earnings released

MedX Health Corp. Announces Management Appointments

MedX Health Corp announced that it expects to receive CAD 2 million in funding

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter